TScan Therapeutics

TScan Therapeutics is a biopharmaceutical company that specializes in developing immunotherapy treatments for cancer. Their main focus is on T-cell receptor (TCR) engineered T cell therapies (TCR-T) for patients with cancer. Their lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are being developed to eliminate residual leukemia and prevent relapse after stem cell transplantation. ...